Literature DB >> 18061963

Longterm treatment benefits are best reflected by patient reported outcomes.

C Vibeke Strand, Bruce Crawford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18061963

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

1.  Effects of rheumatoid arthritis on household chores and leisure-time activities.

Authors:  Mauri Leino; Sini Tuominen; Laura Pirilä; Risto Tuominen
Journal:  Rheumatol Int       Date:  2015-06-20       Impact factor: 2.631

2.  Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis.

Authors:  Sang-Cheol Bae; Suk Chyn Gun; Chi Chiu Mok; Rezaul Khandker; Henk W Nab; Andrew S Koenig; Bonnie Vlahos; Ron Pedersen; Amitabh Singh
Journal:  BMC Musculoskelet Disord       Date:  2013-01-08       Impact factor: 2.362

3.  Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial.

Authors:  Vibeke Strand; Philip Mease; Gerd R Burmester; Enkeleida Nikaï; Geoffroy Coteur; Ronald van Vollenhoven; Bernard Combe; Edward C Keystone; Arthur Kavanaugh
Journal:  Arthritis Res Ther       Date:  2009-11-12       Impact factor: 5.156

4.  Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial.

Authors:  Vibeke Strand; Eduardo Mysler; Robert J Moots; Gene V Wallenstein; Ryan DeMasi; David Gruben; Koshika Soma; Noriko Iikuni; Josef S Smolen; Roy Fleischmann
Journal:  RMD Open       Date:  2019-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.